Washington: A low-cost drug, which is widely used as a pain killer in developing countries, can kill drug-resistant tuberculosis (TB) -- a feat few currently approved TB drugs can accomplish, say researchers.Weill Cornell Medical College researchers point to a potential new therapy for the more than half million people worldwide whose TB has become resistant to standard drug treatments.But their main worry is that the effective drug, oxyphenbutazone, may never be tested in TB clinical trials.Weill Cornell`s Carl Nathan and his team found what they called the "completely surprising" ability of oxyphenbutazone to kill drug-resistant TB after testing thousands of approved drugs against the bacteria.
Beware of antibiotics in your chicken!
Will write my own book to tell the truth: Sonia
Dawood ties up with Nigeria`s Boko Haram?
Eating chicken could make you immune to antibiotics